"10.1371_journal.pone.0018018","plos one","2011-05-09T00:00:00Z","Friederike Mahn; Philipp Hüllemann; Ulrich Gockel; Mathias Brosz; Rainer Freynhagen; Thomas R Tölle; Ralf Baron","Sektion Neurologische Schmerzforschung und -therapie, Klinik für Neurologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany; CASQUAR GmbH, Computerassoziierte Qualitätssicherung und Rehabilitationsförderung, Bochum, Germany; StatConsult GmbH, Magdeburg, Germany; Zentrum für Anästhesiologie, Intensivmedizin, Schmerztherapie und Palliativmedizin, Benedictus Krankenhaus Tutzing, Tutzing, Germany; Klinik für Neurologie, Technische Universität München, München, Germany","Conceived and designed the experiments: RB RF TRT MB UG. Analyzed the data: MB FM PH RB TRT RF. Wrote the paper: FM PH RB. Acquisition of data: FM PH UG MB RF TRT RB.","In the past three years, RF has received research support, consulting, or speaking fees from Astellas, Grünenthal, Lilly/Boehringer, Pfizer, UCB/Schwarz. RB has received research support, consulting, or speaking fees from Grünenthal, Lilly/Boehringer-Ingelheim, Mundipharma, Pfizer, Medtronic, Schwarz Pharma, Allergan, Genzyme, UCB BioSciences, Astellas, Sanofi Pasteur, Eisai, Novartis. TRT has received honoraria as a consultant and/or speaker from Grünenthal, Eli Lilly and Company, Boehringer-Ingelheim Pharmaceuticals, Pfizer, UCB Pharma, and Mundipharma. PH and FM have received research support, consulting, or speaking fees from Grünenthal and Pfizer. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.",NA,NA,NA,"2011","05","Friederike Mahn","FM",7,TRUE,5,NA,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
